James A. Robinson Jr.

James A. Robinson Jr. discloses dealings in 2 companies, chiefly UroGen Pharma Ltd. and Eledon Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 26 February 2025 to 26 August 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 28 August 2026, the filings show an option exercise in UroGen Pharma Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.